|
|
||||||||
Department of Surgery, Duke University Medical Center, Durham, North Carolina
* Address correspondence to Dr D'Amico, Duke University Medical Center, Box 3496, Duke South, White Zone, Room 3589, Durham, NC 27710 (Email: damic001{at}mc.duke.edu).
Metastasectomy is the only curative option for some patients with secondary pulmonary malignancy. Many studies suggest a survival benefit in selected patients if complete resection of pulmonary metastases is accomplished. There are several operative approaches that may be used, with the goal of complete resection and with minimal parenchymal loss. Evaluation for resection must include ascertainment of control of the primary tumor and assessment of the ability to achieve complete resection. Minimally invasive approaches may offer advantages in quality of life outcomes, with equivalent oncologic outcomes.
This article has been cited by other articles:
![]() |
S. Kim, H. C. Ott, C. D. Wright, J. C. Wain, C. Morse, H. A. Gaissert, D. M. Donahue, D. J. Mathisen, and M. Lanuti Pulmonary Resection of Metastatic Sarcoma: Prognostic Factors Associated With Improved Outcomes Ann. Thorac. Surg., November 1, 2011; 92(5): 1780 - 1787. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |